BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1149009)

  • 1. Concanavalin A (NSC-143504): its action on experimental tumor cells and possible use in cancer chemotherapy.
    Lin H; Bruce WR; Walcroft MJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):319-26. PubMed ID: 1149009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
    Simmons RL; Rios A
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 6. Hybrid cells derived from fusion of TA2-Ha ascites carcinoma with normal fibroblasts. II. Characterization of isoantigenic variant sublines.
    Friberg S; Klein G; Wiener F; Harris H
    J Natl Cancer Inst; 1973 May; 50(5):1269-86. PubMed ID: 4712591
    [No Abstract]   [Full Text] [Related]  

  • 7. Decrease in agglutinability of cultured tumor cells to concanavalin-A at the plateau of cell growth.
    Goto M; Kataoka Y; Goto K; Yokoyama T; Sato H
    Gan; 1972 Aug; 63(4):505-6. PubMed ID: 5081628
    [No Abstract]   [Full Text] [Related]  

  • 8. Virus expression and immunoprophylaxis of a murine lymphoma.
    Sekine I; Vredevoe DL; Hays EF
    J Natl Cancer Inst; 1975 Mar; 54(3):727-31. PubMed ID: 164567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thy-1+ epidermal cells proliferate in response to concanavalin A and interleukin 2.
    Nixon-Fulton JL; Bergstresser PR; Tigelaar RE
    J Immunol; 1986 Apr; 136(8):2776-86. PubMed ID: 2870120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoiesis-stimulating and anti-tumor effects of repeated administration of diclofenac in mice with transplanted fibrosarcoma cells.
    Hofer M; Hoferová Z; Fedorocko P; Macková NO
    Physiol Res; 2002; 51(6):629-32. PubMed ID: 12511188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
    Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
    Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lectins on tumorigenicity of AKR lymphoma cells of varying malignancy.
    Leibovici J; Avichezer D; Gilboa-Garber N
    Anticancer Res; 1986; 6(6):1411-5. PubMed ID: 3813494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concanavalin A-induced agglutination of human leukemic and lymphoma cells.
    Maca RD
    Cancer Res; 1976 Apr; 36(4):1218-21. PubMed ID: 1063062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of syngeneic RNA pretreatment on the growth of an allogeneic mouse tumor.
    Comerauer ME; Dosne Pasqualini C
    Acta Physiol Lat Am; 1976; 26(2):150-3. PubMed ID: 1030178
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectin potentiation of BCG-contact-mediated antitumor action.
    Poduval TB; Seshadri M; Sundaram K
    J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in concanavalin A-mediated agglutination of hormone-dependent mouse mammary tumour cells during serial transplantation.
    Sluyser M; van der Valk M; van Blitterswijk WJ
    Br J Cancer; 1980 Mar; 41(3):348-55. PubMed ID: 7387828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agglutination reactions of spontaneous canine tumour cells, induced by concanavalin A, demonstrated by an isotopic assay.
    Betton GR
    Int J Cancer; 1976 Nov; 18(5):687-96. PubMed ID: 992901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.